BioCryst Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
Hey, good afternoon, everybody. My name is Jon Wolleben, senior analyst here at JMP Securities. I am pleased to have BioCryst Pharmaceuticals here and CEO Jon Stonehouse joining us. So please enjoy the lunch entertainment, and we'll save some time for questions at the end. But Jon, thanks for coming.
Yeah, thank you for having me.
Questions & Answers
And then BioCryst, it's a company that's been around for quite some time. And you guys have had some great success as of late. For those who may not be familiar, what are you guys working on and what's been working so well recently?
Sure. Before I do that, just a reminder, I'll be making some forward-looking statements. They have risks and the risk factors can be found on our website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
